Metformin is first-line therapy for type 2 diabetes mellitus (T2DM). Concerns that metformin may accumulate and precipitate the severe adverse event lactic acidosis when kidney function is poor has led to its contraindication in patients with reduced kidney function. Most references discourage its use at a creatinine clearance